Creo Medical Group PLC Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Creo Medical Group PLC Stock Forecast and Price Target
If the average 2024 price target of £1.00 recently set by prominent experts for Creo Medical Group PLC is met, there would be a potential upside of approximately 177.78% from the last closing price in April, 2024. The high estimate is £1.00, and the low is £0.99.
177.78% Upside
Creo Medical Group PLC Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Creo Medical Group PLC's Price has seen an increase, rising from £0.00 to £0.00. This represents a growth of 100.00%. Analysts predict that Creo Medical Group PLC's Fair Value will increase in the upcoming year, reaching £0.38. This would represent an increase of 100.00%. Over the next seven years, experts predict that Creo Medical Group PLC's Fair Value will grow at a rate of 100.00%.
Creo Medical Group PLC Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Creo Medical Group PLC's Revenue has seen an increase, rising from £9.43M to £27.17M. This represents a growth of 188.12%. According to 0 prominent analysts, Creo Medical Group PLC's Revenue will fall by 25.77% in the next year, reaching £20.17M. By 2030, professionals believe that Creo Medical Group PLC's Revenue will decrease by 22.05%, reaching £21.18M – a concerning trend for the company.
.jpg)
Creo Medical Group PLC EBITDA Forecast for 2023 - 2025 - 2030
Creo Medical Group PLC's EBITDA has grown in the last two years, jumping from £-22.15M to £-28.50M – an increase of 28.67%. In the next year, 3 analysts estimate that Creo Medical Group PLC's EBITDA will decrease by 64.84%, reaching £-10.02M. For the next seven years, the forecast is for EBITDA to grow by 126.55%.
Creo Medical Group PLC EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Creo Medical Group PLC's EBIT has increased by 32.87%, going from £-23.15M to £-30.76M. According to 3 analysts, Creo Medical Group PLC's EBIT will fall by 53.15% in the next year, reaching £-14.41M. Professionals believe that By 2030, Creo Medical Group PLC's EBIT will fall to £7.07M – a 122.99% decrease from its current value.
Creo Medical Group PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Creo Medical Group PLC's EPS has seen an increase, rising from £-0.13 to £0.00. This represents a growth of 100.00%. Analysts predict that Creo Medical Group PLC's EPS will increase in the upcoming year, reaching £-0.03. This would represent an increase of 100.00%. Over the next seven years, experts predict that Creo Medical Group PLC's EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)